tiprankstipranks
Advertisement
Advertisement

PTHS Stock Latest News

Pelthos Therapeutics to Present at Jefferies Healthcare Conference
Company AnnouncementsPelthos Therapeutics to Present at Jefferies Healthcare Conference
6d ago
8K
PTHS
Pelthos Therapeutics Earnings Call Shows Strong Launch
PremiumCompany Announcements
Pelthos Therapeutics Earnings Call Shows Strong Launch
16d ago
PTHS
Pelthos Therapeutics price target raised to $66 from $62 at Oppenheimer
PremiumThe Fly
Pelthos Therapeutics price target raised to $66 from $62 at Oppenheimer
19d ago
PTHS
Pelthos Therapeutics reports Q1 EPS ($3.58), consensus ($3.09)
PremiumThe Fly
Pelthos Therapeutics reports Q1 EPS ($3.58), consensus ($3.09)
20d ago
PTHS
Pelthos Therapeutics Reports Strong Q1 Growth for ZELSUVMI
PremiumCompany Announcements
Pelthos Therapeutics Reports Strong Q1 Growth for ZELSUVMI
20d ago
8K
PTHS
PTHS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPTHS Upcoming Earnings Report: What to Expect?
23d ago
PTHS
Pelthos Highlights Infectious Disease Portfolio at Investor Meetings
Premium
Company Announcements
Pelthos Highlights Infectious Disease Portfolio at Investor Meetings
2M ago
8K
PTHS
Pelthos Therapeutics Appoints John M. Gay as CFO
Premium
Company Announcements
Pelthos Therapeutics Appoints John M. Gay as CFO
2M ago
8K
PTHS
Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO
PremiumThe Fly
Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO
2M ago
PTHS
Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
PTHS
Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
PTHS
Pelthos Therapeutics doses first patient in CT2000 trial
PremiumThe Fly
Pelthos Therapeutics doses first patient in CT2000 trial
2M ago
PTHS
Pelthos Therapeutics Inc trading resumes
PremiumThe FlyPelthos Therapeutics Inc trading resumes
2M ago
PTHS
Pelthos Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Pelthos Therapeutics Inc trading halted, volatility trading pause
2M ago
PTHS
Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer
Premium
The Fly
Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer
3M ago
PTHS
Pelthos Highlights 2025 Results and Portfolio Expansion Progress
PremiumCompany Announcements
Pelthos Highlights 2025 Results and Portfolio Expansion Progress
3M ago
8K
PTHS
Pelthos Therapeutics reports Q4 EPS ($6.87) vs. ($3.19) last year
PremiumThe Fly
Pelthos Therapeutics reports Q4 EPS ($6.87) vs. ($3.19) last year
3M ago
PTHS
PTHS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PTHS Earnings this Week: How Will it Perform?
3M ago
PTHS
Pelthos Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Pelthos Therapeutics initiated with an Overweight at Piper Sandler
3M ago
PTHS
Pelthos Therapeutics price target lowered to $55 from $57 at Roth Capital
PremiumThe FlyPelthos Therapeutics price target lowered to $55 from $57 at Roth Capital
3M ago
PTHS
Pelthos Therapeutics files $200M mixed securities shelf
Premium
The Fly
Pelthos Therapeutics files $200M mixed securities shelf
4M ago
PTHS
Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
Premium
The Fly
Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer
4M ago
PTHS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >